Antibodies against transglutaminases, peptidylarginine deiminase and citrulline in rheumatoid arthritis - New pathways to epitope spreading

Clinical and Experimental Rheumatology

Volumn 24, Issue 1, 2006, Pages 12-18

  Roth, E Bodil ^a,b   Stenberg, Pål ^a   Book, Christina ^b   Sjöberg, Klas ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Autoimmunity; Citrulline; Coeliac; Epitope spreading; Factor XIII; Methotrexate; Peptidylarginine deiminase; Rheumatoid; Transglutaminase

Indexed keywords

AUROTHIOMALATE; AZATHIOPRINE; CHLOROQUINE; CITRULLINE; EPITOPE; METHOTREXATE; PROTEIN ARGININE DEIMINASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; SALAZOSULFAPYRIDINE;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; GUINEA PIG; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CITRULLINE; EPITOPES; FEMALE; GUINEA PIGS; HUMANS; HYDROLASES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; METHOTREXATE; MIDDLE AGED; RECOMBINANT PROTEINS; TRANSGLUTAMINASES;

EID: 33645088938     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. van VENROOIJ WJ, HAZES JM, VISSER H: Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 2002; 60: 383-8.
2. VOSSENAAR ER, ZENDMAN AJ, van VENROOIJ WJ, PRUIJN GJ: PAD, a growing family of citruillinating enzymes: genes, features and involvement in disease. Bioessays 2003; 25: 1106-18.
3. TARCSA E, MAREKOV LN, MEI G, MELINO G, LEE SC, STEINERT PM: Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem 1996; 271: 30709-16.
4. SUZUKI A, YAMADA R, CHANG X et al.: Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003; 34: 395-402.
5. MASSON-BESSIERE C, SEBBAG M, GIRBALNEUHAUSER E et al.: The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001; 166: 4177-84.
6. DIETERICH W, EHNIS T, BAUER M et al.: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797-801.
7. MOLBERG O, McADAM SN, SOLLID LM: Role of tissue transglutaminase in celiac disease. J Pediatr Gastroenterol Nutr 2000; 30: 232-40.
8. DIETERICH W, ESSLINGER B, SCHUPPAN D: Pathomechanisms in celiac disease. Int Arch Allergy Immunol 2003; 132: 98-108.
9. FARRACE MG, PICARELLI A, DI TOLA M et al.: Presence of anti-"issue" transglutaminase antibodies in inflammatory intestinal diseases: an apoptosis-associated event? Cell Death Differ 2001; 8: 767-70.
10. TARCSA E, MAREKOV LN, ANDREOLI J et al.: The fate of trichohyalin. Sequential post-translational modifications by peptidyl-arginine deiminase and transglutaminases. J Biol Chem 1997; 272: 27893-901.
11. LEHMANN PV, FORSTHUBER T, MILLER A, SERCARZ EE: Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992; 358: 155-7.
12. ROTH EB, SJOBERG K, STENBERG P: Biochemical and immuno-pathological aspects of tissue transglutaminase in coeliac disease. Autoimmunity 2003; 36: 221-6.
13. AGARDH D, ROTH B, LERNMARK A, STENBERG P: Calcium activation of tissue transglutaminase in radioligand binding and enzyme-linked autoantibody immunoassays in childhood celiac disease. Clinica Chimica Acta 2005; 358: 95-103.
14. NISSINEN R, PAIMELA L, JULKUNEN H et al.: Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren syndrome. Scand J Rheumatol 2003; 32: 337-42.
15. PICARELLI A, DI TOLA M, SABBATELLA L et al.: Anti-tissue transglutaminase antibodies in arthritic patients: a disease-specific finding? Clin Chem 2003; 49: 2091-4.
16. BIZZARO N, VILLALTA D, TONUTTI E, TAMPOIA M, BASSETTI D, TOZZOLI R: Association of celiac disease with connective tissue diseases and autoimmune diseases of the digestive tract. Autoimmun Rev 2003; 2: 358-63.
17. RIENTE L, CHIMENTI D, PRATESI F et al.: Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis. J Rheumatol 2004; 31: 920-4.
18. WOLLHEIM FA, STENBERG, P, MARSAL, L: Characterisation of transglutaminases in plasma and synovial fluid from patients with arthritis. 15th International Congress of Rheumatology, Paris, 1981.
19. SEIVING B, OHLSSON K, LINDER C, STENBERG P: Transglutaminase differentiation during maturation of human blood monocytes to macrophages. Eur J Haematol 1991; 46: 263-71.
20. BOHM I: Decrease of B-cells and autoanti-bodies after low-dose methotrexate. Biomed Pharmacother 2003; 57: 278-81.
21. CICCOCIOPPO R, DI SABATINO A, ARA C et al.: Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa. Clin Exp Immunol 2003; 134: 516-24.
22. FLECKENSTEIN B, QIAO SW, LARSEN MR, JUNG G, ROEPSTORFF P, SOLLID LM: Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J Biol Chem 2004; 279: 17607-16.